Soni Manmeet Singh — SEC Form 4 filings
SEC reporting owner CIK 1569769. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-04-04 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 50,000 shares, $722,250 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 25,000 shares @ $14.46 ($361,500) in Summit Therapeutics Inc., filed 2026-06-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | COO and CFO, Director | 6 | 2 legs · 50,000 sh · $722,250 | — | 5 |
| PULSE BIOSCIENCES, INC. (PLSE) | Director | 4 | — | — | 4 |
Form 4 filings — Soni Manmeet Singh
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Summit Therapeutics Inc. (SMMT) | Purchase (P): 25,000 @ $14.46 · Purchase (P): 25,000 @ $14.43 | EDGAR |
| 2025-10-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 53,361 @ $18.74 | EDGAR |
| 2025-08-19 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 11,200,000 (derivative) | EDGAR |
| 2024-09-13 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 44,052 @ $22.70 | EDGAR |
| 2024-08-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 2,800,000 (derivative) | EDGAR |
| 2024-08-13 | 4 | PULSE BIOSCIENCES, INC. (PLSE) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Pulse Biosciences, Inc. (PLSE) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-04-04 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 1,100,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1569769 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →